You just read:

Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohn's Disease

News provided by

Alder BioPharmaceuticals Inc.

Aug 27, 2012, 08:00 ET